Мы используем файлы cookie.
Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
KannaLife
Другие языки:

    KannaLife

    Подписчиков: 0, рейтинг: 0
    Kannalife Sciences Inc.
    Type Private (Subsidiary)
    Industry Pharmaceutical
    Founded 2010
    Founders Dean Petkanas, Thoma Kikis
    Headquarters Doylestown, Pennsylvania
    Total assets Exclusive License of patent US 6630507 
    Website http://kannalife.com
    KannaLife was granted the Exclusive License by NIH-OTT for the commercialization of patent US 6630507  “Cannabinoids as Antioxidants and Neuroprotectants."

    Kannalife Sciences Inc. , a subsidiary of Neuropathix, Inc., is a bio-pharmaceutical and phyto-medical company based in Doylestown, Pennsylvania founded by Dean Petkanas and Thoma Kikis. Kannalife was formed in 2010 and is involved in the research and development of novel new therapeutic agents designed to reduce oxidative stress, and act as immuno-modulators and neuroprotectants.

    In 2011, the company was granted an Exclusive License by National Institutes of Health – Office of Technology Transfer (NIH-OTT) for the Commercialization of patent US 6630507 , “Cannabinoids as Antioxidants and Neuroprotectants."

    Kannalife is currently conducting research and development at the Pennsylvania Biotechnology Center of Bucks County in Doylestown, PA, for a target drug candidate, KLS-13019 to treat Chemotherapy-induced peripheral neuropathy, Hepatic encephalopathy, Mild Traumatic Brain Injury and CTE, an oxidative stress related disease that affects the cognitive and behavioral functions, and the wellness of the brain.

    Kannalife was featured in Sports Illustrated article on using cannabinoids to treat Concussions and CTE.


    Новое сообщение